RecruitingPhase 4NCT06317805
Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
Studying Drug- or toxin-induced pulmonary arterial hypertension
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- AOP Orphan Pharmaceuticals AG
- Intervention
- Generic treprostinil sodium + Standard of Care (Double Oral)(drug)
- Enrollment
- 110 enrolled
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2023 – 2027
Study locations (19)
- Ordensklinikum Linz, Linz, Austria
- Medical University Vienna, Vienna, Austria
- Fakultní Nemocnice Olomouc, Olomouc, Czechia
- Všeobecná fakultní nemocnice v Praze, Prague, Czechia
- Hôpital Bicêtre-- Assistance Publique Hopitaux de Paris, Paris, France
- Hôpitaux Universitaires de Strasbourg, Strasbourg, France
- DRK Kliniken Berlin Westend, Berlin, Germany
- University Hospital Carl Gustav Carus of Technical University Dresden, Dresden, Germany
- Universitätsmedizin Greifswald, Greifswald, Germany
- Gottsegen National Cardiovascular lnstitute, Budapest, Hungary
- Medical University of Szeged, Szeged, Hungary
- Sapienza University of Rome, Rome, Italy
- John Paul II Hospital Krakow, Krakow, Poland
- Fryderyk Chopin Hospital in European Health Centre Otwock, Otwock, Poland
- Centro Hospitalar Lisboa Norte - Santa Maria University Hospital, Lisbon, Portugal
- +4 more locations on ClinicalTrials.gov
Collaborators
ANOVA CRO s.r.o. · PharmaLex Belgium · Aixial s.r.o. · GCP-Service International Ltd. & Co. KG
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06317805 on ClinicalTrials.govOther trials for Drug- or toxin-induced pulmonary arterial hypertension
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07529821Additional Effects of Pilates Breathing and Diaphragmatic Breathing Combined With Moderate Intensity Continuous Treadmill Training on Blood Pressure, Chest Expansion, Pulmonary Function and Quality Of Life in Pre-hypertensive PatientsFoundation University Islamabad
- ACTIVE NOT RECRUITINGNCT07312227A Prospective Longitudinal Observational Cohort Study of Pregnant Women Residing at High Altitude in BoliviaMassachusetts General Hospital
- ENROLLING BY INVITATIONNANCT07558460Virtual Reality in Patients With Pulmonary Hypertension: A Randomized Controlled TrialIstanbul University - Cerrahpasa
- RECRUITINGPHASE2NCT07318597Phase 2 Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)Regeneron Pharmaceuticals
- RECRUITINGPHASE1NCT06872112A Study Evaluating the Safety and Tolerability of Artesunate in Patients With Pulmonary Arterial HypertensionJoseph C. Wu
- RECRUITINGPHASE2NCT06351345129 Xenon Imaging in Patients Treated With SotaterceptBastiaan Driehuys
- RECRUITINGPHASE4NCT07140484Sotatercept in Pulmonary Arterial HypertensionUniversity of Alberta
- RECRUITINGPHASE2NCT07175038A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)AllRock Bio, Inc.
See all trials for Drug- or toxin-induced pulmonary arterial hypertension →